KeynoteOral·09:50–10:20The 51% blind spot: Psychedelics, women's health and the opportunity we must not missGrace Blest-Hopley
Psychedelics in psychiatry and psychotherapyOral·10:30–10:55Altered states and the future of psychopathology: Psychedelics in historical and philosophical perspectiveDamiaan DenysOral·10:55–11:20Common factors of psychotherapy in psychedelic-assisted therapy (PAT)Peter Gasser
Symposium·11:50–12:50From experience to outcome: Psychological change processes in psychedelic researchHelena AicherSusanne PrinzÓscar Soto AngonaMax Wolff
KeynoteOral·14:20–15:00From getting high to getting healthy: Recent research on psychoactive drugsHarriet de Wit
KeynoteOral·15:10–15:50From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic useManvir Singh
Symposium·16:20–17:20Rewiring addiction: Psychedelic therapy from brain circuits to lived recoveryCelia MorganRayyan ZafarAlison ChapmanDavid ErritzoeRebecca Harding
Panel·17:30–18:15Toward a western psychedelic practice lineage: standards, care, and the future of practitioner educationDaan KeimanDuncan StillSimon RuffellLéla Mosemghvlishvili
Industry, Policy and Access PathwaysOral·10:30–10:55The state of the psychedelic industry and policyJosh HardmanOral·10:55–11:20Are reimbursement pathways ready for licensed psychedelic therapies in Europe?Floris Wolswijk
Panel·11:50–12:50Political, spiritual and cultural perspectives on ayahuascaÁlvaro TukanoChristian TymBrigitte AdriaensenTarire Mutzarawa
Psychedelics at the end of lifeOral·14:20–14:40Irremediable psychiatric suffering and euthanasia requests: A potential indication for psilocybin treatmentMetten SomersOral·14:40–15:00The right to die well: MAID, psychedelics, and humane end-of-life careHouman Farzin
Participant perspectivesOral·15:10–15:50From patients to partners: Early insights from a patient-led care model following psychedelic treatment (Supported by the Norrsken Mind Lived Experience Fellowship)Leonie Schneider, Ian Roullier, Caroline Lilley
Panel·16:20–17:20Clinical trial experts by experience: A dose of reality (Supported by the Norrsken Mind Lived Experience Fellowship)Leonie SchneiderJo GiblinIan RoullierHannah Harvey
Psychedelic HumanitiesOral·09:50–10:20The psychedelic humanities: A posthuman proposal for the community of psychedelic professionalsDaan F Oostveen
Challenging ExperiencesOral·10:30–10:55Persisting psychological complications following the use of classic psychedelics: A qualitative study of help-seeking experiencesLisa Maria JöbstlOral·10:55–11:20When therapy falls short: A qualitative study of psychotherapy after challenging experiences and the need for psychedelic-informed therapyGuy Simon
Symposium·11:50–12:50Remembering our original nature – ecological dimensions of psychedelics, health, and the selfCecilie Byholt EndresenBrian StaffordSam GandySimon Ruffell
Psychedelics in religious contextsOral·14:20–14:40Crossing orthodox boundaries: The emergence of ayahuasca use in the ultra-orthodox (Haredi) worldJonathan DavidOral·14:40–15:00“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelicsManzar Zare
PAT: Qualitative research in underserved populationsOral·15:10–15:30Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adultsSabrina CluesmanOral·15:30–15:50Accelerated recovery using magnesium ibogaine: Characterizing the subjective experience of its rapid healing from neuropsychiatric disordersClayton Olash
Symposium·16:20–17:20Psychedelics and the intimate self: Sexuality, gender, and relationshipsDee Dee GoldpaughPat SongDaniel Kruger
Symposium·17:30–18:15Asian psychedelia: Family, governance, and postcolonial tensions in psychedelic treatmentsXiaofan SunMinsu YooJennifer Docherty
Panel·18:15–19:15Psychedelic therapy and the boundaries of professional responsibility: Reflections on a recent Dutch disciplinary caseMetten SomersTadeusz HawrotTonnie Prinsen-ReindersWietse Rypkema
KeynoteOral·09:50–10:20The 51% blind spot: Psychedelics, women's health and the opportunity we must not missGrace Blest-Hopley
Psychedelics in psychiatry and psychotherapyOral·10:30–10:55Altered states and the future of psychopathology: Psychedelics in historical and philosophical perspectiveDamiaan DenysOral·10:55–11:20Common factors of psychotherapy in psychedelic-assisted therapy (PAT)Peter Gasser
Symposium·11:50–12:50From experience to outcome: Psychological change processes in psychedelic researchHelena AicherSusanne PrinzÓscar Soto AngonaMax Wolff
KeynoteOral·14:20–15:00From getting high to getting healthy: Recent research on psychoactive drugsHarriet de Wit
KeynoteOral·15:10–15:50From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic useManvir Singh
Symposium·16:20–17:20Rewiring addiction: Psychedelic therapy from brain circuits to lived recoveryCelia MorganRayyan ZafarAlison ChapmanDavid ErritzoeRebecca Harding
Panel·17:30–18:15Toward a western psychedelic practice lineage: standards, care, and the future of practitioner educationDaan KeimanDuncan StillSimon RuffellLéla Mosemghvlishvili
Industry, Policy and Access PathwaysOral·10:30–10:55The state of the psychedelic industry and policyJosh HardmanOral·10:55–11:20Are reimbursement pathways ready for licensed psychedelic therapies in Europe?Floris Wolswijk
Panel·11:50–12:50Political, spiritual and cultural perspectives on ayahuascaÁlvaro TukanoChristian TymBrigitte AdriaensenTarire Mutzarawa
Psychedelics at the end of lifeOral·14:20–14:40Irremediable psychiatric suffering and euthanasia requests: A potential indication for psilocybin treatmentMetten SomersOral·14:40–15:00The right to die well: MAID, psychedelics, and humane end-of-life careHouman Farzin
Participant perspectivesOral·15:10–15:50From patients to partners: Early insights from a patient-led care model following psychedelic treatment (Supported by the Norrsken Mind Lived Experience Fellowship)Leonie Schneider, Ian Roullier, Caroline Lilley
Panel·16:20–17:20Clinical trial experts by experience: A dose of reality (Supported by the Norrsken Mind Lived Experience Fellowship)Leonie SchneiderJo GiblinIan RoullierHannah Harvey
Psychedelic HumanitiesOral·09:50–10:20The psychedelic humanities: A posthuman proposal for the community of psychedelic professionalsDaan F Oostveen
Challenging ExperiencesOral·10:30–10:55Persisting psychological complications following the use of classic psychedelics: A qualitative study of help-seeking experiencesLisa Maria JöbstlOral·10:55–11:20When therapy falls short: A qualitative study of psychotherapy after challenging experiences and the need for psychedelic-informed therapyGuy Simon
Symposium·11:50–12:50Remembering our original nature – ecological dimensions of psychedelics, health, and the selfCecilie Byholt EndresenBrian StaffordSam GandySimon Ruffell
Psychedelics in religious contextsOral·14:20–14:40Crossing orthodox boundaries: The emergence of ayahuasca use in the ultra-orthodox (Haredi) worldJonathan DavidOral·14:40–15:00“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelicsManzar Zare
PAT: Qualitative research in underserved populationsOral·15:10–15:30Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adultsSabrina CluesmanOral·15:30–15:50Accelerated recovery using magnesium ibogaine: Characterizing the subjective experience of its rapid healing from neuropsychiatric disordersClayton Olash
Symposium·16:20–17:20Psychedelics and the intimate self: Sexuality, gender, and relationshipsDee Dee GoldpaughPat SongDaniel Kruger
Symposium·17:30–18:15Asian psychedelia: Family, governance, and postcolonial tensions in psychedelic treatmentsXiaofan SunMinsu YooJennifer Docherty
Panel·18:15–19:15Psychedelic therapy and the boundaries of professional responsibility: Reflections on a recent Dutch disciplinary caseMetten SomersTadeusz HawrotTonnie Prinsen-ReindersWietse Rypkema